274 related articles for article (PubMed ID: 29743538)
1. Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement.
Ganzer R; Arthanareeswaran VKA; Ahmed HU; Cestari A; Rischmann P; Salomon G; Teber D; Liatsikos E; Stolzenburg JU; Barret E
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):175-186. PubMed ID: 29743538
[TBL] [Abstract][Full Text] [Related]
2. Future of focal therapy for the treatment of prostate cancer- european section of urotechnology (ESUT) position.
Barret E; Ganzer R; Salomon G; Fielder M; Celia A; Enikeev D; Martínez-Salamanca JI; Liatsikos E; Gómez Rivas J
Arch Esp Urol; 2019 Mar; 72(2):167-173. PubMed ID: 30855018
[TBL] [Abstract][Full Text] [Related]
3. Target ablation--image-guided therapy in prostate cancer.
Marien A; Gill I; Ukimura O; Betrouni N; Villers A
Urol Oncol; 2014 Aug; 32(6):912-23. PubMed ID: 24411788
[TBL] [Abstract][Full Text] [Related]
4. Morbidity of focal therapy in the treatment of localized prostate cancer.
Barret E; Ahallal Y; Sanchez-Salas R; Galiano M; Cosset JM; Validire P; Macek P; Durand M; Prapotnich D; Rozet F; Cathelineau X
Eur Urol; 2013 Apr; 63(4):618-22. PubMed ID: 23265382
[TBL] [Abstract][Full Text] [Related]
5. Focal therapy of prostate cancer: energies and procedures.
Bozzini G; Colin P; Nevoux P; Villers A; Mordon S; Betrouni N
Urol Oncol; 2013 Feb; 31(2):155-67. PubMed ID: 22795500
[TBL] [Abstract][Full Text] [Related]
6. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
7. Ablation energies for focal treatment of prostate cancer.
Lodeizen O; de Bruin M; Eggener S; Crouzet S; Ghai S; Varkarakis I; Katz A; Dominguez-Escrig JL; Pahernik S; de Reijke T; de la Rosette J
World J Urol; 2019 Mar; 37(3):409-418. PubMed ID: 29943219
[TBL] [Abstract][Full Text] [Related]
8. [Focal therapy of prostate cancer].
Ganzer R; Franiel T; Köllermann J; Kuru T; Baumunk D; Blana A; Hadaschik B; von Hardenberg J; Henkel T; Köhrmann KU; Liehr UB; Machtens S; Roosen A; Salomon G; Schlemmer HP; Sentker L; Wendler J; Witzsch U; Schostak M
Urologe A; 2017 Oct; 56(10):1335-1346. PubMed ID: 28856386
[TBL] [Abstract][Full Text] [Related]
9. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
[TBL] [Abstract][Full Text] [Related]
10. An update on focal therapy for prostate cancer.
Perera M; Krishnananthan N; Lindner U; Lawrentschuk N
Nat Rev Urol; 2016 Nov; 13(11):641-653. PubMed ID: 27670618
[TBL] [Abstract][Full Text] [Related]
11. The role of focal therapy in the management of localised prostate cancer: a systematic review.
Valerio M; Ahmed HU; Emberton M; Lawrentschuk N; Lazzeri M; Montironi R; Nguyen PL; Trachtenberg J; Polascik TJ
Eur Urol; 2014 Oct; 66(4):732-51. PubMed ID: 23769825
[TBL] [Abstract][Full Text] [Related]
12. German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy.
Borkowetz A; Blana A; Böhmer D; Cash H; Ehrmann U; Franiel T; Henkel TO; Höcht S; Kristiansen G; Machtens S; Niehoff P; Penzkofer T; Pinkawa M; Radtke JP; Roth W; Witzsch U; Ganzer R; Schlemmer HP; Grimm MO; Hakenberg OW; Schostak M
Urol Int; 2022; 106(5):431-439. PubMed ID: 35144260
[TBL] [Abstract][Full Text] [Related]
13. Surveillance after prostate focal therapy.
Tay KJ; Amin MB; Ghai S; Jimenez RE; Kench JG; Klotz L; Montironi R; Muto S; Rastinehad AR; Turkbey B; Villers A; Polascik TJ
World J Urol; 2019 Mar; 37(3):397-407. PubMed ID: 29948045
[TBL] [Abstract][Full Text] [Related]
14. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
Valerio M; Cerantola Y; Eggener SE; Lepor H; Polascik TJ; Villers A; Emberton M
Eur Urol; 2017 Jan; 71(1):17-34. PubMed ID: 27595377
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
[TBL] [Abstract][Full Text] [Related]
16. A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review.
Faure Walker NA; Norris JM; Shah TT; Yap T; Cathcart P; Moore CM; Ahmed HU; Emberton M; Minhas S
Urol Oncol; 2018 Feb; 36(2):67-76. PubMed ID: 29277585
[TBL] [Abstract][Full Text] [Related]
17. Focal therapy for prostate cancer.
Polascik TJ; Mouraviev V
Curr Opin Urol; 2008 May; 18(3):269-74. PubMed ID: 18382236
[TBL] [Abstract][Full Text] [Related]
18. Focal therapy in the treatment of localised prostate cancer: primum non nocere.
Challacombe BJ; Murphy DG
Eur Urol; 2013 Apr; 63(4):623-4; discussion 625-6. PubMed ID: 23290301
[No Abstract] [Full Text] [Related]
19. Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic review.
Nicoletti R; Alberti A; Castellani D; Yee CH; Zhang K; Poon DMC; Chiu PK; Campi R; Resta GR; Dibilio E; Pirola GM; Chiacchio G; Fuligni D; Brocca C; Giulioni C; De Stefano V; Serni S; Gauhar V; Ng CF; Gacci M; Teoh JYC
Prostate Cancer Prostatic Dis; 2023 Jul; ():. PubMed ID: 37507479
[TBL] [Abstract][Full Text] [Related]
20. Alternative- and focal therapy trends for prostate cancer: a total population analysis of in-patient treatments in Germany from 2006 to 2019.
Flegar L; Zacharis A; Aksoy C; Heers H; Derigs M; Eisenmenger N; Borkowetz A; Groeben C; Huber J
World J Urol; 2022 Jul; 40(7):1645-1652. PubMed ID: 35562598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
